Document is current
Any future updates will be listed below
-
Authors
Okpara, Chinenye https://orcid.org/0000-0002-8859-7942
Ioannidis, George
Thabane, Lehana
Adachi, Jonathan Derrick
Rabinovich, Alexander
Hewston, Patricia
Lee, Justin
McArthur, Caitlin
Kennedy, Courtney
Woo, Tricia
Boulos, Pauline
Bobba, Raja
Wang, Mimi
Thrall, Samuel
Mangin, Derelie
Marr, Sharon
Armstrong, David
Patterson, Christopher
Bray, Steven
de Wit, Kerstin
Maharaj, Shyam
Misiaszek, Brian
Sookhoo, Jessica Belgrave
Thompson, Karen
Papaioannou, Alexandra
-
Funding
Funding for this research was provided by:
McMaster University
Juravinski Research Institute Canada
- License Information
-
More Information
Article History
Received: 24 February 2023
Accepted: 19 June 2023
First Online: 17 July 2023
Declarations
:
: Ethics approval for the trial was obtained from the Hamilton Integrated Research Ethics Board (HiREB) (file no. 11408). All participants provided a documented verbal informed consent before participating in the trial.
: Not applicable.
: Jonathan D. Adachi, grants/research support — Amgen and Radius; speaker bureau/honoraria — Amgen, Gilead, GSK, and Paladin; consulting fees — Amgen, Gilead, GSK, and Paladin; and past president of Osteoporosis Canada. David Armstrong, co-founder, chief innovation officer, and medical advisory member — A.I. VALI; board member of Canadian Digestive Health Foundation; medical advisory board member of Cinclus Pharma; speaker honorarium — Fresenius Kabi and Takeda; research funding — Nestlé Health Sciences; treasurer of International Working Group for the Classification of Oesophagitis; medical advisory board member of Phathom Pharma; and Douglas family chain in nutrition research. The other authors declare that they have no competing interests.
